Gene Therapy in Ophthalmology Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Gene Therapy in Ophthalmology Market is segmented By Indication (Inherited Retinal Diseases, Acquired Retinal Diseases), By Vector Type (Adeno-associa....
Competitive overview of Gene Therapy in Ophthalmology Market
The major players operating in the gene therapy in ophthalmology market include Johnson & Johnson Innovative Medicine, MeiraGTx, Beacon Therapeutics, Nanoscope Therapeutics, GenSight Biologics, 4D Molecular Therapeutics, Coave Therapeutics, Bionic Sight, Neuropht Therapeutics, Adverum Biotechnologies, EyeVensys, Exegenesis Bio, Atsena Therapeutics, Ocugen, AbbVie, REGENXBIO, Skyline Therapeutics, Huida Gene Therapeutics, Opus Genetics, Spark Therapeutics, Novartis AG, Adverum Biotechnologies, REGENXBIO Inc., and AGTC.
Gene Therapy in Ophthalmology Market Leaders
- Johnson & Johnson Innovative Medicine
- MeiraGTx
- Beacon Therapeutics
- Nanoscope Therapeutics
- GenSight Biologics
*Disclaimer: Major players are listed in no particular order.
Gene Therapy in Ophthalmology Market - Competitive Rivalry, undefined
Gene Therapy in Ophthalmology Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights